Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Ford

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
BMC Research Notes|January 14, 2026
Harmonising definitions of multiple long term conditions for inflammation research: a co-production approachDaniel Asfaw, Charlotte Davies, Elena Kulinskaya, et al.
Public Health in Practice (Oxford, England)|March 19, 2026
Payment mechanisms to improve prevention spending in health care settings: A policy-focused evidence briefIan Holdroyd, Adnaan Ghanchi, Amy Dehn Lunn, et al.
BMJ (Clinical Research Ed.)|October 23, 2015
Difficulty accessing data from randomised trials of drugs for heart failure: a call for actionRobert Fleetcroft, John Ford, Nicholas D Gollop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patientsBin Peng, Michael Hayes, Debra Resta, et al.
Journal of Cardiovascular Pharmacology|February 1, 2013
Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitorJohn Ford, James Milnes, Erich Wettwer, et al.
Journal of Applied Clinical Medical Physics|August 25, 2021
A customizable aluminum compensator system for total body irradiationMadison Naessig, Soleil Hernandez, Nestor Rodrigo Astorga, et al.
Public Health in Practice (Oxford, England)|June 11, 2026
Improving behavioural interventions in healthcare to address the needs of disadvantaged groups: A policy-focused evidence briefAnna Gkiouleka, Sashika Harasgama, Helen Pearce, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2017
XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory CoughMaria G Belvisi, Mark A Birrell, Michael A Wortley, et al.
Lancet (London, England)|June 7, 2015
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trialG Kees Hovingh, John J P Kastelein, Sander J H van Deventer, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 30, 2026
Missing by omission: the hidden heart of cardiovascular inequity in the UKClare R Goyder, Caroline Mitchell, Charlotte James, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
BMC Research Notes|January 14, 2026
Harmonising definitions of multiple long term conditions for inflammation research: a co-production approachDaniel Asfaw, Charlotte Davies, Elena Kulinskaya, et al.
Public Health in Practice (Oxford, England)|March 19, 2026
Payment mechanisms to improve prevention spending in health care settings: A policy-focused evidence briefIan Holdroyd, Adnaan Ghanchi, Amy Dehn Lunn, et al.
BMJ (Clinical Research Ed.)|October 23, 2015
Difficulty accessing data from randomised trials of drugs for heart failure: a call for actionRobert Fleetcroft, John Ford, Nicholas D Gollop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patientsBin Peng, Michael Hayes, Debra Resta, et al.
Journal of Cardiovascular Pharmacology|February 1, 2013
Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitorJohn Ford, James Milnes, Erich Wettwer, et al.
Journal of Applied Clinical Medical Physics|August 25, 2021
A customizable aluminum compensator system for total body irradiationMadison Naessig, Soleil Hernandez, Nestor Rodrigo Astorga, et al.
Public Health in Practice (Oxford, England)|June 11, 2026
Improving behavioural interventions in healthcare to address the needs of disadvantaged groups: A policy-focused evidence briefAnna Gkiouleka, Sashika Harasgama, Helen Pearce, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2017
XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory CoughMaria G Belvisi, Mark A Birrell, Michael A Wortley, et al.
Lancet (London, England)|June 7, 2015
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trialG Kees Hovingh, John J P Kastelein, Sander J H van Deventer, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 30, 2026
Missing by omission: the hidden heart of cardiovascular inequity in the UKClare R Goyder, Caroline Mitchell, Charlotte James, et al.
Pageof 11